|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Wayne State University |
|---|---|
| Information provided by: | Wayne State University |
| ClinicalTrials.gov Identifier: | NCT00790348 |
Purpose
The purpose of this study is to see the effect of Januvia on Ghrelin levels in patients with diabetes.
| Condition |
|---|
|
Type 2 Diabetes |
| Study Type: | Observational |
| Study Design: | Cross-Sectional |
| Official Title: | Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes |
Serum of patients will be kept for future studies
| Estimated Enrollment: | 45 |
| Study Start Date: | July 2008 |
| Estimated Primary Completion Date: | July 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Patients who on Januvia
|
|
2
Patients on Janumet (Combination of Januvia and Metformin)
|
|
3
Patients on Metformin
|
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients with type 2 diabetes on oral agent that require Metformin or Januvia only
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Michigan | |
| Wayne State University | Recruiting |
| Detroit, Michigan, United States, 48201 | |
| Contact: Berhane Seyoum, MD 313-745-4008 bseyoum@med.wayne.edu | |
| Principal Investigator: Berhane Seyoum, MD, MPH | |
More Information
| Responsible Party: | Wayne State University ( Berhane Seyoum ) |
| Study ID Numbers: | 0709005250 |
| Study First Received: | November 12, 2008 |
| Last Updated: | November 12, 2008 |
| ClinicalTrials.gov Identifier: | NCT00790348 |
| Health Authority: | United States: Institutional Review Board |
|
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Metabolic disorder Glucose Metabolism Disorders Sitagliptin |
